Effects of crosslinking on the physical solid-state and dissolution properties of 3D-printed theophylline tablets - 08/12/21

Doi : 10.1016/j.stlm.2021.100031 
Hele Anderspuk a, b, 1, Laura Viidik a, 1, , Kristjan Olado a, Karin Kogermann a, Anne Juppo b, Jyrki Heinämäki a, Ivo Laidmäe a, c
a Institute of Pharmacy, Faculty of Medicine, University of Tartu, Nooruse Str. 1, 50411 Tartu, Estonia 
b Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, Viikinkaari 5E, 00014 University of Helsinki, Finland 
c Department of Immunology, Institute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Ravila Str. 19, 50411 Tartu, Estonia 

Corresponding author at: University of Tartu, Faculty of Medicine, Institute of Pharmacy, Nooruse Str. 1, 50411 Tartu, Estonia.University of TartuFaculty of MedicineInstitute of PharmacyNooruse Str. 1Tartu50411Estonia

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

4-hydroxybenzophenone successfully aids UV- or nitrogen-environment gamma-radiation crosslinking of polyethylene oxide based 3D printed tablets.
Increasing the number of printing layers in the polyethylene oxide based theophylline loaded 3D-printed tablets resulted in a slower drug release in vitro.
Gamma-radiation in a nitrogen environment and UV-crosslinking made the carrier polymer (PEO) less water-soluble, but faster drug release behavior was found with the crosslinked 3D-printed tablets compared to that of non-crosslinked tablets.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Crosslinking is an established treatment to alter the physicochemical and functional properties of polymers through the creation of bonds between the polymer chains. Polymers can be crosslinked via radiation in the presence of photo-initiator. The aim of the present study was to formulate 3D-printed theophylline (THEO) tablets using polyethylene oxide (PEO) as a carrier polymer, and to study the influence of crosslinking on the drug release behavior. The tablets were 3D-printed using the aqueous solution of PEO and THEO (80:20 w/w) with a micro-extrusion-based printing setup. A photo-initiator (4-hydroxybenzophenone) was added into the printing solutions, and the injectability of the solutions was investigated prior to printing. The 3D-printed tablets were crosslinked after printing using ultraviolet (UV) or gamma-radiation, and crosslinking was verified by means of Fourier-transform infrared (FTIR) spectroscopy. The maximum injection force of aqueous printing solutions of PEO and THEO was close to that observed with the pure PEO solution. Increasing the number of printing layers in the 3D-printed tablets resulted in a slower drug release in vitro. Gamma-radiation in a nitrogen environment and UV-crosslinking made the carrier polymer (PEO) less water-soluble, but such crosslinking did not affect the release rate of the tablets. Surprisingly, even faster drug release behavior was found with the crosslinked 3D-printed tablets compared to that of non-crosslinked tablets. More research work is needed on the impact of 3D-printed tablet layering thickness and crosslinking for tailoring drug release behavior.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Keywords : 3D-printing, UV-crosslinking, Gamma-radiation crosslinking, Drug release, Polyethylene oxide, Theophylline


Mappa


© 2021  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 4

Articolo 100031- dicembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • 3D-Printing in surgery: Beyond bone structures. A review
  • L Krauel, A Valls-Esteve, A Tejo-Otero, F Fenollosa-Artés

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.